glp-1 receptor agonist kidney outcomes semaglutide flow trial 2024 results Effects of Once-Weekly on Disease by KDIGO Risk Category in the SUSTAIN 6 Cardiovascular, Kidney, and Safety Outcomes – Updated evidence on cardiovascular and

Chitra Gantra explains that she's in favor of prescribing GLP-1s to adults until they're age 65 (via American Academy of Medical Colleges)

Based on these studies, we expected that the SSTR5a would improve glucose tolerance in a gut-derived, GLP-1dependent manner during an OGTT in vivo, whereas the SSTR2a would be less effective

No Artificial Color, Flavor, or Sweetener, No Preservatives, No Sugar, No Milk, No Corn, No Soy, No Egg, No Lactose, No Gluten, No Wheat, No Yeast, No Fish

NICE doesnt recommend routine free T3 testing for an underactive thyroid, because your free T3 levels rarely change your treatment plan

This evolving integration of metabolic and aesthetic therapies reflects the growing importance of the aesthetic courses for doctors at HubMed Ed , which support clinicians in staying at the forefront of peptide-based interventions